Russell Ellison

Russell H.
Ellison is currently President & Director at Rockwell Transportation, Inc. Former positions include President, Chief Executive Officer & Director at Rockwell Medical, Inc. from 2020 to 2022; Chairman, Chief Executive Officer & President at Ventrus Biosciences, Inc. from 2013 to 2014; Chief Executive Officer at Promedior, Inc. in 2018; President & Chief Executive Officer at Bond Biosciences, Inc. from 2016 to 2018; Chairman at CorMedix, Inc.; Director at Cougar Biotechnology, Inc. in 2009; Director at Mt.
Cook Pharma, Inc.; Independent Director at ProSanos Corp.; Director at Janssen Oncology, Inc.; Executive Director at Torreya Partners LLC from 2015 to 2018; Director at Assembly Biosciences, Inc. in 2015; Executive Vice President at Paramount BioCapital Asset Management, Inc.; Chief Medical Officer & VP-Medical Affairs at Hoffmann-La Roche, Inc. from 1997 to 2002; Vice President-Clinical Development at Kyntra Bio, Inc. from 2005 to 2007; Executive Vice President at Paramount BioSciences LLC from 2007 to 2010; Chief Medical Officer & VP-Medical Affairs at Sanofi-Synthelabo, Inc. from 2002 to 2004; and Managing Partner at Alameda Consulting LLC from 2015 to 2018.
Education includes a doctorate from the University of British Columbia and graduate studies at the London School of Hygiene & Tropical Medicine.